SuperX AI (SUPX) installs new CFO and independent director in board overhaul

Rhea-AI Filing Summary

SuperX AI Technology Limited reported several leadership and board changes. Effective May 27, 2026, Chun Kit (Anderson) Yu resigned as interim Chief Financial Officer and Executive Director, and Yuet Yiu Charissa Miu resigned as an independent director and committee member, each without disagreement with the company or its management.

On the same date, the board appointed Guili (Julia) Miao as Deputy Chief Executive Officer, Chief Financial Officer and Executive Director, bringing roughly 20 years of capital-markets-focused finance experience. The board also appointed Kazushige Nakahashi as an independent director and Chairperson of the Compensation Committee and reconstituted the audit, compensation, and nominating committees.

After these changes, the board consists of seven directors, with three executive directors and four independent directors, and continues to rely on Nasdaq’s home country exemption from a majority-independent board requirement.

Insights

Corporate governance analyst

SuperX AI refreshes finance leadership and board committees while maintaining independence standards.

The company replaces its interim Chief Financial Officer with an experienced permanent appointee, Guili Miao, who also becomes Deputy CEO and an Executive Director. This consolidates financial and strategic leadership under a single seasoned capital markets professional.

Board independence is reaffirmed through the appointment of Kazushige Nakahashi as an independent director and committee chair, and by moving Shen Pao Hua Paul to lead the Audit Committee as its financial expert. These moves keep audit and compensation oversight in the hands of independent directors.

The board now has seven members, including four independent directors, while relying on the foreign private issuer home country exemption from Nasdaq’s majority-independent requirement. Future disclosures in company filings may further detail how these leadership changes influence strategy and risk oversight.

Key Figures

Effective date of changes: May 27, 2026 Board size after changes: 7 directors Independent directors count: 4 independent directors +2 more

5 metrics

Effective date of changes May 27, 2026 Resignations, appointments and committee reconstitution effective on this date

Board size after changes 7 directors Three executive directors and four independent directors after reconstitution

Independent directors count 4 independent directors Board composition following appointments and resignations

Experience of new CFO ≈20 years Guili Miao’s finance and capital markets experience highlighted in biography

Nasdaq home country exemption Rule 5615(a)(3) Company relies on exemption from majority-independent board requirement

Key Terms

foreign private issuer, independent director, audit committee financial expert, Nasdaq Listing Rule 5605(a)(2), +2 more

6 terms

foreign private issuer regulatory

"As a foreign private issuer, the Company relies on the home country exemption"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

independent director regulatory

"the Board appointed Mr. Kazushige Nakahashi as an independent director of the Company"

An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.

audit committee financial expert regulatory

"Chairperson and audit committee financial expert of the Audit Committee"

A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.

Nasdaq Listing Rule 5605(a)(2) regulatory

"qualifies as an “independent director” within the meaning of Nasdaq Listing Rule 5605(a)(2)"

Nasdaq Listing Rule 5605(a)(2) sets the criteria Nasdaq uses to decide whether a company’s board members are independent, listing examples of relationships or ties that would disqualify a director from being considered independent. Investors care because a board with genuinely independent directors acts like an impartial referee overseeing management decisions, reducing conflicts of interest and improving the chance that shareholder interests are protected and corporate decisions are scrutinized effectively.

Rule 10A-3 regulatory

"and Rule 10A-3 under the Securities Exchange Act of 1934, as amended"

home country exemption regulatory

"relies on the home country exemption under Nasdaq Listing Rule 5615(a)(3)"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 05/27/2026 - 07:02 AM Accepted by SEC EDGAR 05/27/2026 - 07:01 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-42013

SuperX AI Technology Limited

30 Pasir Panjang Road

#06-31, Mapletree Business City

Singapore 117440

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒    Form 40-F ☐

Resignation of Interim Chief Financial Officer and Executive Director

Effective May 27, 2026, Mr. Chun Kit (Anderson) Yu (“Mr. Yu”) stepped down as the interim Chief Financial Officer and as an Executive Director of SuperX AI Technology Limited (the “Company”), in connection with the appointment of Ms. Guili Miao as Chief Financial Officer described below. Mr. Yu’s resignation was not the result of any disagreement with the Company, the board of directors (the “Board”) or management on any matter relating to the Company’s operations, policies or practices. Following his resignation, Mr. Yu will no longer serve as a director or officer of the Company.

Resignation of Independent Director

Effective May 27, 2026, Ms. Yuet Yiu Charissa Miu (“Ms. Miu”) resigned as an independent director of the Company, including her roles as Chairperson and audit committee financial expert of the Audit Committee and as a member of the Compensation Committee and the Nominating and Corporate Governance Committee. Ms. Miu’s resignation was not the result of any disagreement with the Company, the Board or management on any matter relating to the Company’s operations, policies or practices.

Appointment of Deputy Chief Executive Officer, Chief Financial Officer and Executive Director

On April 30, 2026, the Board appointed Ms. Guili Miao (Julia Miao) (“Ms. Miao”) as the Deputy Chief Executive Officer, Chief Financial Officer and Executive Director of the Company, effective May 27, 2026.

The biographical information of Ms. Miao is set forth below:

Ms. Miao is an experienced finance executive with approximately 20 years of comprehensive experience specializing in corporate finance, accounting, financial reporting, investor relations, capital raising and corporate transactions, focusing primarily on the Hong Kong and mainland China capital markets. Since September 2020, and prior to joining the Company, Ms. Miao served as Deputy Chief Executive Officer and Chief Financial Officer of a pharmaceutical company listed on the Main Board of The Stock Exchange of Hong Kong Limited. From January 2019 to August 2020, she served as General Manager of Investor Relations at another Hong Kong Main Board-listed pharmaceutical group. Ms. Miao began her career in Hong Kong in January 2005, and between January 2005 and December 2018 held a number of senior financial leadership positions, including Executive Director, Chief Financial Officer, Finance Vice President and Deputy General Manager, across pharmaceutical and real estate enterprises based in Hong Kong and mainland China. Throughout her career, she has developed expertise in financial management, statutory financial reporting, private fundraising, investor relations, mergers and acquisitions, and Hong Kong capital market initial public offerings and post-listing compliance. Ms. Miao holds a Master of Business Administration from The University of Hong Kong. She is a Chartered Accountant (CA) of the Institute of Singapore Chartered Accountants (ISCA) and a fellow member of each of the Association of Chartered Certified Accountants (FCCA), the Chartered Institute of Management Accountants (CIMA) and the Chartered Global Management Accountants (CGMA).

In connection with her appointment, the Company and Ms. Miao entered into an employment agreement, dated May 4, 2026, with the Company.

There are no arrangements or understandings between Ms. Miao and any other person pursuant to which she was appointed, and there are no family relationships between Ms. Miao and any director or executive officer of the Company. There are no transactions involving Ms. Miao that would be required to be disclosed under Item 7.B of Form 20-F.

1

Appointment of Independent Director

Effective May 27, 2026, the Board appointed Mr. Kazushige Nakahashi (“Mr. Nakahashi”) as an independent director of the Company and as Chairman of the Compensation Committee. Based on the information provided by Mr. Nakahashi in connection with his appointment, the Board determined that Mr. Nakahashi qualifies as an “independent director” within the meaning of Nasdaq Listing Rule 5605(a)(2) and Rule 10A-3 under the Securities Exchange Act of 1934, as amended.

The biographical information of Mr. Nakahashi is set forth below:

Mr. Kazushige Nakahashi has over 30 years of management experience in information systems development and renewable energy infrastructure. Since September 2003, Mr. Nakahashi has served as President and Chief Executive Officer of Affinity Power Co., Ltd. (formerly Start Soft Japan / iNC Corporation), where he is responsible for the company’s overall strategic planning and business development, including the design and development of core business systems such as the settlement system of the Japan Exchange and Toshiba point-of-sale systems in collaboration with securities firms (including Nomura Securities), the provision since 2012 of uninterruptible power supply solutions for urban traffic signal management systems to Japanese government transportation authorities, and the development and operation of solar energy storage systems and renewable power plant projects. From February 2008 to March 2010, Mr. Nakahashi served as Managing Director of IHI-SJC Environmental Technology (China) Co., Ltd., a member of the IHI Group (TSE: 7013). From April 1994 to May 2003, he served as a Research Associate at Toho Research Institute, Inc. Mr. Nakahashi holds a Master of Arts in International Studies from the Graduate School of Area Studies of Tokyo University of Foreign Studies.

There are no arrangements or understandings between Mr. Nakahashi and any other person pursuant to which he was appointed, and there are no family relationships between Mr. Nakahashi and any director or executive officer of the Company. There are no transactions involving Mr. Nakahashi that would be required to be disclosed under Item 7.B of Form 20-F. In connection with his appointment, the Company and Mr. Nakahashi entered into a director offer letter, dated May 27, 2026.

Reconstitution of Board Committees

Effective May 27, 2026, in connection with the foregoing changes, the Board reconstituted its standing committees. To fill the Audit Committee chair and financial-expert vacancy created by Ms. Miu’s resignation, Mr. Shen Pao Hua Paul, a Certified Public Accountant, moved from the Compensation Committee to chair the Audit Committee, and Mr. Nakahashi succeeded him as Chairperson of the Compensation Committee. As reconstituted: the Audit Committee shall consist of Mr. Shen Pao Hua Paul (Chairperson and Audit Committee Financial Expert), Mr. Shao Wei and Mr. Kazushige Nakahashi; the Compensation Committee shall consist of Mr. Kazushige Nakahashi (Chairperson), Mr. Shao Wei and Mr. Shen Pao Hua Paul; and the Nominating and Corporate Governance Committee shall consist of Mr. Shao Wei (Chairperson), Mr. Shen Pao Hua Paul and Mr. Kazushige Nakahashi. The Board has determined that each of Mr. Shen, Mr. Shao and Mr. Nakahashi satisfies the “independence” requirements of Section 5605(a)(2) of the Nasdaq Listing Rules and Rule 10A-3 under the Securities Exchange Act of 1934, as amended, that each member of the Audit Committee further satisfies the additional independence requirements applicable to audit committee members under Rule 10A-3, and that Mr. Shen qualifies as an “audit committee financial expert.”

Following the foregoing changes, the Company’s Board is composed of seven (7) directors, comprising three (3) executive directors and four (4) independent directors. As a foreign private issuer, the Company relies on the home country exemption under Nasdaq Listing Rule 5615(a)(3) and is not required to maintain a board comprising a majority of independent directors.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SuperX AI Technology Limited
Date: May 27, 2026	By:	/s/ Guili Miao
	Name:	Ms. Guili Miao
	Title:	Chief Financial Officer

3

FAQ

What leadership changes did SuperX AI Technology Limited (SUPX) announce in May 2026?

SuperX AI announced that Chun Kit (Anderson) Yu resigned as interim Chief Financial Officer and Executive Director, and Yuet Yiu Charissa Miu resigned as an independent director. The changes are effective May 27, 2026, and were stated not to result from any disagreement with the company.

Who is the new Chief Financial Officer of SuperX AI Technology Limited (SUPX)?

The board appointed Guili (Julia) Miao as Deputy Chief Executive Officer, Chief Financial Officer and Executive Director, effective May 27, 2026. She brings around 20 years of experience in corporate finance, capital raising, investor relations, and Hong Kong and mainland China capital markets-focused financial leadership roles.

What board and committee changes did SUPX make around May 27, 2026?

SuperX AI appointed Kazushige Nakahashi as an independent director and Chairperson of the Compensation Committee and moved Shen Pao Hua Paul to chair the Audit Committee. The audit, compensation, and nominating committees were reconstituted with independent directors meeting Nasdaq and Rule 10A-3 independence standards.

How many independent directors does SuperX AI Technology Limited (SUPX) now have?

Following the reported changes, SuperX AI’s board has seven directors, including three executive directors and four independent directors. The company, as a foreign private issuer, relies on the Nasdaq Listing Rule 5615(a)(3) home country exemption from maintaining a majority of independent directors.

Did the resignations at SUPX involve disagreements with management or the board?

The filing states that both Chun Kit (Anderson) Yu’s resignation as interim CFO and Executive Director and Yuet Yiu Charissa Miu’s resignation as an independent director were not the result of any disagreement with the company, its board, or management on operations, policies, or practices.

What qualifications does SUPX’s new CFO, Guili Miao, bring to the role?

Guili Miao has about 20 years of experience in corporate finance, accounting, financial reporting, investor relations, capital raising, and transactions, primarily in Hong Kong and mainland China. She holds an MBA from The University of Hong Kong and multiple professional accounting designations, including CA and FCCA.